Open AccessThe clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ
Author(s) -
Islam M. Miligy,
Michael S. Toss,
Sho Shiino,
Georgette Oni,
Binafsha Manzoor Syed,
Hazem Khout,
Qing Tan,
Andrew Green,
R. Douglas Macmillan,
John F.R. Robertson,
Emad A. Rakha
Publication year - 2020
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/s41416-020-1023-3
Subject(s) - medicine , ductal carcinoma , breast cancer , oncology , estrogen receptor , gynecology , cancer
Oestrogen receptor (ER) in invasive breast cancer (BC) predicts response to endocrine therapy (ET) and provides prognostic value. In this study, we investigated the value of ER expression in ductal carcinoma in situ (DCIS) in terms of outcome and the impact on ET decision.